Nanofiber implant delivers three drugs, doubles survival in glioblastoma mice
Researchers at the University of Cincinnati and Johns Hopkins have developed a nanofiber implant that delivers a combination of three drugs to treat glioblastoma. In animal studies, this synergistic approach significantly improved survival rates compared to single-drug treatments.
Why it matters
Glioblastoma is an aggressive and common form of brain cancer; this delivery system could offer a more effective, localized way to treat tumors while minimizing systemic side effects.
Nanofiber implant delivers three drugs, doubles survival in glioblastoma mice
The article is a straightforward report on scientific research findings without political or ideological framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in